Your browser doesn't support javascript.
loading
Prolactin as an adrenocorticotropic hormone: Prolactin signalling is a conserved key regulator of sexually dimorphic adrenal gland function in health and disease.
Lalli, Enzo; Figueiredo, Bonald C.
  • Lalli E; EXPOGEN-CANCER CNRS International Research Project, 660 route des Lucioles, Sophia Antipolis, Valbonne, 06560, France.
  • Figueiredo BC; Inserm, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.
Bioessays ; 44(10): e2200109, 2022 10.
Article en En | MEDLINE | ID: mdl-36000778
ABSTRACT
A large number of previous reports described an effect of the pituitary hormone prolactin (PRL) on steroid hormone production by the adrenal cortex. However, those studies remained anecdotal and were never converted into a conceptual and mechanistic framework, let alone being translated into clinical care. In the light of our recently published landmark study where we described PRL signalling as a pivotal regulator of the sexually dimorphic adrenal phenotype in mouse and of adrenal androgen production in humans, we present here the overarching hypothesis that PRL signalling increases the activity of Steroidogenic Factor-1 (SF-1/NR5A1), a transcription factor that has an essential role in adrenal gland development and function, to regulate adrenal cortex growth and hormonal production in physiological and pathological conditions. PRL can then be considered as a bona fide adrenocorticotropic hormone synergizing with ACTH in the endocrine control of adrenal cortex function.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prolactina / Hormona Adrenocorticotrópica Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prolactina / Hormona Adrenocorticotrópica Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article